Ajouter aux favoris   Ajouter cette page à mon bookmark --- SOCIAL BOOKMARKING --- Digg Furl del.icio.us Netscape

Republic of Korea Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Republic of Korea wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Republic of Korea

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents 2
1.1 List of Tables 12
1.2 List of Figures 15
2 Introduction 18
2.1 What Is This Report About? 18
2.2 Definitions 18
2.2.1 Wound Care Management 18
3 Healthcare Sector Review 20
3.1 Healthcare Expenditure 20
3.2 Healthcare Infrastructure 23
3.3 Healthcare Policy 27
4 Wound Care Management in Republic of Korea 28
4.1 Wound Care Management Overall Revenues (2000-2012) 28
4.2 Wound Care Management Overall Volume (2000-2012) 34
4.3 Wound Care Management Overall Company Shares (2005-2006) 37
5 Wound Closure Devices in Republic of Korea 38
5.1 Wound Closure Devices Overall Revenues (2000-2012) 38
5.1.1 Skin Closure Devices Overall Revenues (2000-2012) 42
5.1.2 Hemostats Overall Revenues (2000-2012) 44
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 46
5.2 Wound Closure Devices Overall Volume (2000-2012) 48
5.2.1 Skin Closure Devices Overall Volume (2000-2012) 49
5.2.2 Hemostats Overall Volume (2000-2012) 52
5.2.3 Tissue Sealants Overall Volume (2000-2012) 54
5.3 Wound Closure Devices Average Price (2000-2012) 56
5.3.1 Hemostats Average Price (2000-2012) 56
5.3.2 Tissue Sealants Average Price (2000-2012) 58
5.3.3 Skin Closure Devices Average Price (2000-2012) 60
5.4 Wound Closure Devices Distribution Share (2000-2012) 62
5.5 Wound Closure Devices Company Share (2000-2012) 63
6 Ostomy in Republic of Korea 64
6.1 Ostomy Overall Revenue (2000-2012) 64
6.2 Ostomy Overall Volume (2000-2012) 66
6.3 Ostomy Average Price (2000-2012) 68
6.4 Ostomy Distribution Share (2005-2006) 70
6.5 Ostomy Company Share (2005-2006) 71
7 Advanced Wound Management in Republic of Korea 72
7.1 Advanced Wound Management Overall Revenue (2000-2012) 72
7.2 Advanced Wound Management Overall Volume (2000-2012) 74
7.3 Advanced Wound Management Average Price (2000-2012) 76
7.4 Advanced Wound Management Distribution Share (2005-2006) 78
7.5 Advanced Wound Management Company Share (2005-2006) 79
8 Traditional Wound Management in Republic of Korea 80
8.1 Traditional Wound Management Overall Revenue (2000-2012) 80
8.2 Traditional Wound Management Overall Volume (2000-2012) 82
8.3 Traditional Wound Management Average Price (2000-2012) 84
8.4 Traditional Wound Management Distribution Share (2000-2012) 86
8.5 Traditional Wound Management Company Share (2000-2012) 87
9 Compression Therapy in Republic of Korea 88
9.1 Compression Therapy Overall Revenue (2000-2012) 88
9.2 Compression Therapy Category Volume (2000-2012) 90
9.3 Compression Therapy Average Price (2000-2012) 92
9.4 Compression Therapy Distribution Share (2000-2012) 94
9.5 Compression Therapy Company Share (2000-2012) 95
10 Covidien Ltd./Tyco Healthcare Company Profile 96
10.1 Company Overview 96
10.2 Business Overview 96
10.2.1 Imaging Solutions 96
10.2.2 Medical Devices 97
10.2.3 Medical Supplies 97
10.2.4 Pharmaceutical Products 98
10.2.5 Retail Products 98
10.2.6 Products 99
10.2.7 History 100
10.3 Value Chain Analysis 101
10.3.1 Manufacturing 101
10.3.2 Product Development 102
10.3.3 Sales and Marketing 103
10.4 SWOT Analysis 103
10.4.1 Covidien Ltd./Tyco Healthcare Strengths 104
10.4.2 Covidien Ltd./Tyco Healthcare Weaknesses 104
10.4.3 Covidien Ltd./Tyco Healthcare Opportunities 105
10.4.4 Covidien Ltd./Tyco Healthcare Threats 106
10.5 Financial and Operational Review 107
10.5.1 Financial Statements 107
10.5.2 Financial Ratios 108
10.6 Locations And Subsidiaries 109
10.7 Financial Deals Landscape 111
10.7.1 Covidien Signs An Agreement With Allergan 111
10.7.2 Covidien Acquires Scandius Biomedical 112
10.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million 114
10.7.4 Covidien And BioSynthema Enter Into Licensing Agreement 115
10.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien 117
10.7.6 Covidien To Sell European Incontinence Business 119
10.7.7 Covidien To Acquire Tissue Science Laboratories 120
10.8 Recent Developments 123
10.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007 123
10.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend 123
10.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case 123
10.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results 124
10.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend 125
10.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results 126
10.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results 126
10.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent 128
10.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend 128
10.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results 128
10.9 Covidien Ltd./Tyco Healthcare Pipeline Products 130
10.9.1 PleuraSeal Lung Sealant System 130
10.9.2 Sandman Intro CPAP Device 131
11 3M Company Profile 133
11.1 Company Overview 133
11.2 Business Overview 133
11.2.1 Consumer and Office 133
11.2.2 Display and Graphics 133
11.2.3 Electro and Communications 134
11.2.4 Health Care 135
11.2.5 Industrial and Transportation 135
11.2.6 Safety, Security and Protection Services 136
11.2.7 Products 137
11.3 Value Chain Analysis 139
11.3.1 Manufacturing 139
11.3.2 Product Development 140
11.3.3 Sales and Marketing 140
11.4 SWOT Analysis 141
11.4.1 3M Company Strengths 141
3M Company Weaknesses 142
3M Company Opportunities 142
3M Company Threats 143
11.5 Financial and Operational Review 144
11.6 Locations And Subsidiaries 145
11.7 Financial Deals Landscape 147
11.7.1 3M Canada Acquires Les Entreprises Solumed 147
11.7.2 3M Acquires Bondo 149
11.7.3 3M Acquires Lingualcare 151
11.7.4 3M Acquires Abzil Industria E Comercio 153
11.7.5 3M Acquires Neo Plast 154
11.7.6 3M Acquires Assets Of DMS Chile 157
11.7.7 3M Acquires Business Of Innovative Paper Technologies 159
11.7.8 3M Acquires Powell 161
11.7.9 Gen-Probe Signs An Agreement With 3M Company 163
11.7.10 3M Acquires Acolyte Biomedica 165
11.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp. 167
11.7.12 3M Sells Its Pharmaceutical Business To Meda AB 170
11.7.13 3M Acquires SoftMed Systems 172
11.7.14 3M Sells its Pharmaceuticals Business to Graceway 174
11.7.15 Gen-Probe Signs An Agreement With 3M 176
11.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital 178
11.7.17 3M Acquires Biotrace International 180
11.7.18 Ekahau Secures $16 Million In Additional Funding 182
11.7.19 3M Acquires Brontes Technologies 185
11.7.20 3M acquires Nylonge Corp 187
11.7.21 3M Signs An Agreement With ClozeX Medical 189
11.7.22 3M Acquires OMNII Oral Pharmaceuticals 191
11.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway 193
11.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB 196
11.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital 199
11.7.26 3M Acquires Accuspray Application Technologies Inc. 202
11.7.27 3M to acquire Rochford Thompson Equipment 204
11.7.28 3M To Acquire Aearo Technologies From Permira 206
11.7.29 Permira To Sell Aearo Technologies To 3M 208
11.8 Recent Developments 211
11.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses 211
11.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State 211
11.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia 213
11.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia 213
11.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year 213
11.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend 213
11.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery 213
11.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend 214
11.8.9 May 08, 2007: 3M Declares Quarterly Dividend 214
11.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests 214
12 Ethicon, Inc. Company Profile 215
12.1 Company Overview 215
12.2 Business Overview 215
12.2.1 Products 216
12.3 Locations And Subsidiaries 217
12.4 Financial Deals Landscape 219
12.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON 219
12.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON 221
12.4.3 ETHICON Acquires Vascular Control Systems 222
12.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON 223
13 Smith & Nephew Plc Company Profile 226
13.1 Company Overview 226
13.2 Business Overview 226
13.2.1 Advanced Wound Management 226
13.2.2 Endoscopy 227
13.2.3 Reconstruction 227
13.2.4 Trauma and Clinical Therapies 228
13.2.5 Products 229
13.2.6 History 229
13.3 Value Chain Analysis 233
13.3.1 Manufacturing 233
13.3.2 Product Development 234
13.3.3 Sales and Marketing 235
13.4 SWOT Analysis 235
13.4.1 Smith & Nephew Plc Strengths 235
13.4.2 Smith & Nephew Plc Weaknesses 236
13.4.3 Smith & Nephew Plc Opportunities 236
13.4.4 Smith & Nephew Plc Threats 237
13.5 Financial and Operational Review 238
13.6 Locations And Subsidiaries 239
13.7 Financial Deals Landscape 241
13.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein 241
13.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services 241
13.7.3 Smith & Nephew Acquires Plus Orthopedics Holding 242
13.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement 244
13.7.5 Smith & Nephew Acquires BlueSky Medical Group 245
13.7.6 Smith & Nephew Enters Into An Agreement With Covalon 246
13.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories 247
13.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew 247
13.7.9 Smith & Nephew Acquires Osteobiologics 248
13.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement 249
13.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity 251
13.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew 252
13.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies 253
13.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft 254
13.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement 254
13.7.16 Smith & Nephew Acquires VERSAJET From HydroCision 255
13.7.17 Smith & Nephew Terminates Acquisition Of Biomet 257
13.8 Recent Developments 258
13.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend 258
13.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results 258
13.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation 259
13.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM 260
13.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails 261
13.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend 261
13.8.7 May 03, 2007: Smith & Nephew Appoints New CEO 261
13.9 Smith & Nephew Plc Pipeline Products 263
13.9.1 R3 Modular resurfacing Acetabular system 263
13.9.2 R3 Ceramic-on-ceramic Acetabular System 263
14 The HARTMANN GROUP Company Profile 264
14.1 Company Overview 264
14.2 Business Overview 264
14.2.1 Incontinence Management 264
14.2.2 Operating Theater Management 264
14.2.3 Other GROUP Activities 265
14.2.4 Wound Management 265
14.2.5 Products 266
14.2.6 History 267
14.3 Value Chain Analysis 269
14.3.1 Manufacturing 269
14.3.2 Product Development 270
14.3.3 Sales and Marketing 270
14.4 SWOT Analysis 270
14.4.1 HARTMANN GROUP Strengths 271
14.4.2 HARTMANN GROUP Weaknesses 271
14.4.3 HARTMANN GROUP Opportunities 272
14.4.4 HARTMANN GROUP Threats 272
14.5 Financial and Operational Review 274
14.6 Locations And Subsidiaries 275
14.7 Recent Developments 277
14.7.1 Mar 17, 2008: Hartmann Declares 2007 Results 277
14.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia 278
14.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm 279
14.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results 279
15 Regulation System 281
15.1 Medical Equipment Approval Process 281
15.1.1 Classification 281
15.1.2 Premarket Notification for Class I Devices 282
15.1.3 Pre-market Approval for Class II, III and IV Devices 282
15.1.4 License Fee 283
15.1.5 License Application Processing Duration 283
15.2 Post-market Surveillance 284
16 Pricing and Reimbursement 285
17 Distribution Structure 288
17.1 Distribution Structure 288
18 APPENDIX 289
18.1 Global Markets Direct Research Methodology 289
18.2 Coverage 290
18.3 Secondary Research 290
18.4 Primary Research 291
18.5 Models 291
18.6 Forecasts 292
18.7 Expert Panels 292
18.8 Currency Conversion 293
18.9 Contact Us 294
18.10 Disclaimer 294



1.1 List of Tables
Table 1: Hospital Wards by Specialty in Republic of Korea, 2003-2007 24
Table 2: Doctors by Specialty in Republic of Korea, 2003-2007 25
Table 3: Healthcare Institutions in Republic of Korea, 2001-2005 26
Table 4: Healthcare Personnel in Republic of Korea, 1975-2002 26
Table 5: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), 2000-2012 28
Table 6: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 29
Table 7: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 30
Table 8: Wound Care Management, Republic of Korea, Category Revenues ($ mn), 2000-2012 31
Table 9: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Historic, 2000-2007 32
Table 10: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Forecast, 2007-2012 33
Table 11: Wound Care Management, Republic of Korea, Category Volume (Units), 2000-2012 34
Table 12: Wound Care Management, Republic of Korea, Category Volume (Units), Historic, 2000-2007 35
Table 13: Wound Care Management, Republic of Korea, Category Volume (Units), Forecast, 2007-2012 36
Table 14: Wound Care Management, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006 37
Table 15: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 38
Table 16: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 39
Table 17: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Historic, 2000-2007 40
Table 18: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Forecast, 2007-2012 41
Table 19: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 42
Table 20: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 43
Table 21: Hemostats, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 44
Table 22: Hemostats, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 45
Table 23: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 46
Table 24: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 47
Table 25: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 48
Table 26: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 49
Table 27: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 50
Table 28: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 51
Table 29: Hemostats, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 52
Table 30: Hemostats, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 53
Table 31: Tissue Sealants, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 54
Table 32: Tissue Sealants, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 55
Table 33: Hemostats, Republic of Korea, Average Price ($), Historic, 2000-2007 56
Table 34: Hemostats, Republic of Korea, Average Price ($), Forecast, 2007-2012 57
Table 35: Tissue Sealants, Republic of Korea, Average Price ($), Historic, 2000-2007 58
Table 36: Tissue Sealants, Republic of Korea, Average Price ($), Forecast, 2007-2012 59
Table 37: Skin Closure Devices, Republic of Korea, Average Price ($), Historic, 2000-2007 60
Table 38: Skin Closure Devices, Republic of Korea, Average Price ($), Forecast, 2007-2012 61
Table 39: Wound Closure Devices, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006 62
Table 40: Wound Closure Devices, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006 63
Table 41: Ostomy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 64
Table 42: Ostomy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 65
Table 43: Ostomy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 66
Table 44: Ostomy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 67
Table 45: Ostomy, Republic of Korea, Average Price ($), Historic, 2000-2007 68
Table 46: Ostomy, Republic of Korea, Average Price ($), Forecast, 2007-2012 69
Table 47: Ostomy, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006 70
Table 48: Ostomy, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006 71
Table 49: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 72
Table 50: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 73
Table 51: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 74
Table 52: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 75
Table 53: Advanced Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007 76
Table 54: Advanced Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012 77
Table 55: Advanced Wound Management, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006 78
Table 56: Advanced Wound Management, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006 79
Table 57: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 80
Table 58: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 81
Table 59: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 82
Table 60: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 83
Table 61: Traditional Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007 84
Table 62: Traditional Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012 85
Table 63: Traditional Wound Management, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006 86
Table 64: Traditional Wound Management, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006 87
Table 65: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 88
Table 66: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 89
Table 67: Compression Therapy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 90
Table 68: Compression Therapy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 91
Table 69: Compression Therapy, Republic of Korea, Average Price ($), Historic, 2000-2007 92
Table 70: Compression Therapy, Republic of Korea, Average Price ($), Forecast, 2007-2012 93
Table 71: Compression Therapy, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006 94
Table 72: Compression Therapy, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006 95
Table 73: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007 103
Table 74: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007 107
Table 75: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007 108
Table 76: Covidien Ltd./Tyco Healthcare, Other Locations 109
Table 77: Covidien Ltd./Tyco Healthcare, Subsidiaries 110
Table 78: 3M Company, SWOT Analysis, 2006 141
Table 79: 3M Company, Financial Statements, USD Million, 2002-2006 144
Table 80: 3M Company, Financial and Operational Overview, USD Million, 2002-2006 145
Table 81: 3M Company, Subsidiaries 146
Table 82: Ethicon, Inc., Other Locations 217
Table 83: Ethicon, Inc., Subsidiaries 218
Table 84: Smith & Nephew Plc, SWOT Analysis, 2006 235
Table 85: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006 238
Table 86: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006 239
Table 87: Smith & Nephew Plc, Other Locations 240
Table 88: HARTMANN GROUP, SWOT Analysis, 2006 270
Table 89: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006 274
Table 90: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006 275
Table 91: HARTMANN GROUP, Subsidiaries 276
Table 92: Classification of Medical Equipment in Republic of Korea 281
Table 93: Currency Conversion from USD to Local Currency at 2007 Constant Rate 293



1.1 List of Figures
Figure 1: Healthcare Financing in Republic of Korea, 2007 21
Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006 22
Figure 3: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), 2000-2012 28
Figure 4: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 29
Figure 5: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 30
Figure 6: Wound Care Management, Republic of Korea, Category Revenues ($ mn), 2000-2012 31
Figure 7: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Historic, 2000-2007 32
Figure 8: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Forecast, 2007-2012 33
Figure 9: Wound Care Management, Republic of Korea, Category Volume (Units), 2000-2012 34
Figure 10: Wound Care Management, Republic of Korea, Category Volume (Units), Historic, 2000-2007 35
Figure 11: Wound Care Management, Republic of Korea, Category Volume (Units), Forecast, 2007-2012 36
Figure 12: Wound Care Management, Republic of Korea, Company Share (%), 2006 37
Figure 13: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 38
Figure 14: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 39
Figure 15: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Historic, 2000-2007 40
Figure 16: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Forecast, 2007-2012 41
Figure 17: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 42
Figure 18: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 43
Figure 19: Hemostats, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 44
Figure 20: Hemostats, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 45
Figure 21: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 46
Figure 22: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 47
Figure 23: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 48
Figure 24: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 49
Figure 25: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 50
Figure 26: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 51
Figure 27: Hemostats, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 52
Figure 28: Hemostats, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 53
Figure 29: Tissue Sealants, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 54
Figure 30: Tissue Sealants, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 55
Figure 31: Hemostats, Republic of Korea, Average Price ($), Historic, 2000-2007 56
Figure 32: Hemostats, Republic of Korea, Average Price ($), Forecast, 2007-2012 57
Figure 33: Tissue Sealants, Republic of Korea, Average Price ($), Historic, 2000-2007 58
Figure 34: Tissue Sealants, Republic of Korea, Average Price ($), Forecast, 2007-2012 59
Figure 35: Skin Closure Devices, Republic of Korea, Average Price ($), Historic, 2000-2007 60
Figure 36: Skin Closure Devices, Republic of Korea, Average Price ($), Forecast, 2007-2012 61
Figure 37: Wound Closure Devices, Republic of Korea, Distribution Share (%), 2006 62
Figure 38: Wound Closure Devices, Republic of Korea, Company Share (%), 2006 63
Figure 39: Ostomy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 64
Figure 40: Ostomy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 65
Figure 41: Ostomy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 66
Figure 42: Ostomy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 67
Figure 43: Ostomy, Republic of Korea, Average Price ($), Historic, 2000-2007 68
Figure 44: Ostomy, Republic of Korea, Average Price ($), Forecast, 2007-2012 69
Figure 45: Ostomy, Republic of Korea, Company Share (%), 2006 71
Figure 46: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 72
Figure 47: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 73
Figure 48: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 74
Figure 49: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 75
Figure 50: Advanced Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007 76
Figure 51: Advanced Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012 77
Figure 52: Advanced Wound Management, Republic of Korea, Distribution Share (%), 2006 78
Figure 53: Advanced Wound Management, Republic of Korea, Company Share (%), 2006 79
Figure 54: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 80
Figure 55: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 81
Figure 56: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 82
Figure 57: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 83
Figure 58: Traditional Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007 84
Figure 59: Traditional Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012 85
Figure 60: Traditional Wound Management, Republic of Korea, Distribution Share (%), 2006 86
Figure 61: Traditional Wound Management, Republic of Korea, Company Share (%), 2006 87
Figure 62: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 88
Figure 63: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 89
Figure 64: Compression Therapy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 90
Figure 65: Compression Therapy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 91
Figure 66: Compression Therapy, Republic of Korea, Average Price ($), Historic, 2000-2007 92
Figure 67: Compression Therapy, Republic of Korea, Average Price ($), Forecast, 2007-2012 93
Figure 68: Compression Therapy, Republic of Korea, Distribution Share (%), 2006 94
Figure 69: Compression Therapy, Republic of Korea, Company Share (%), 2006 95
Figure 70: Covidien Ltd./Tyco Healthcare, Value Chain Analysis 101
Figure 71: 3M Company, Value Chain Analysis 139
Figure 72: Smith & Nephew Plc, Value Chain Analysis 233
Figure 73: HARTMANN GROUP, Value Chain Analysis 269
Figure 74: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007 286
Figure 75: Medical Device Pricing System in Republic of Korea, 2007 287
Figure 76: Global Markets Direct Methodology 289